C12Y 306/03049
Channel-conductance-controlling atpase
Official title: Channel-conductance-controlling ATPase (3.6.3.49)
C12Y306/03049 (Channel-conductance-controlling atpase) appears on 7 US grants and 11 published applications in this corpus.
Search patents in C12Y- Granted patents
- 7
- Published applications
- 11
- Assignees
- 8
- Inventors
- 31
- Latest grant
- 7 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 2 | 2 |
| 2016 | 0 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 2 |
| 2025 | 1 | 1 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- CFTR mRNA compositions and related methods and uses7 Apr 2026US 12,594,295 B2ethris GmbH
- CFTR-modulating compositions and methods8 Apr 2025US 12,270,029 B2Flagship Pioneering Innovations VI, LLC
- CFTR MRNA compositions and related methods and uses29 Nov 2022US 11,510,937 B2ethris GmbH
- CFTR MRNA compositions and related methods and uses24 Sep 2019US 10,420,791 B2Translate Bio, Inc.
- CFTR mRNA compositions and related methods and uses25 Jul 2017US 9,713,626 B2ethris GmbH
- Cftr-modulating compositions and methods5 Jun 2025US 2025/0179482 A1Flagship Pioneering Innovations VI, LLC
- Functional porosome manipulation26 Sep 2024US 2024/0316152 A1Porosome Therapeutics, Inc.
- Cftr-modulating compositions and methods21 Mar 2024US 2024/0093186 A1Flagship Pioneering Innovations VI, LLC
- Cftr mrna compositions and related methods and uses28 Sep 2023US 2023/0302039 A1ethris GmbH
- Cftr mrna compositions and related methods and uses13 Feb 2020US 2020/0046752 A1ethris GmbH
Most cited
By later US patents
- CFTR mRNA compositions and related methods and uses44US 9,181,321 B2ethris GmbH · 2015
- CFTR mRNA compositions and related methods and uses15US 9,713,626 B2ethris GmbH · 2017
- Modified human U1snRNA molecule, a gene encoding for the modified human U1snRNA molecule, an expression vector including the gene, and the use thereof in gene therapy6US 9,074,207 B2Universita' Degli Studi Di Ferrara · 2015
- CFTR-modulating compositions and methods3US 12,270,029 B2Flagship Pioneering Innovations VI, LLC · 2025
- CFTR MRNA compositions and related methods and uses2US 10,420,791 B2Translate Bio, Inc. · 2019